Nasdaq: RXDX

Ignyta, Inc.

Ignyta, Inc. is a biotechnology company catalyzing personalized medicine in cancer. The company is pursuing an integrated Rx/Dx strategy of combining highly targeted drug discovery and development with companion diagnostics for patient selection.